<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04066842</url>
  </required_header>
  <id_info>
    <org_study_id>10-918</org_study_id>
    <nct_id>NCT04066842</nct_id>
  </id_info>
  <brief_title>Vitamin D in Systemic Sclerosis Patients With Periodontitis</brief_title>
  <official_title>Evaluation Of Vitamin D In Systemic Sclerosis Patients With Periodontitis: A Possible Role In Cardiovascular Disease Risk Progression?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Messina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D has been considered to possess anti-inflammatory and antimicrobial activity which
      may be a link for the known interaction of Systemic Sclerosis (SSc) and coronary heart
      disease (CHD). This study investigated the association between serum vitamin D levels and SSc
      and periodontitis in patients with SSc, CP and with CHD.

      Furthermore, the objective was to determine if periodontitis and CHD had an impact on serum
      vitamin D levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using a cross-sectional design, a total of 42 patients with SSc, 43 patients with CHD, 41
      patients with both SSc and CP, and 42 healthy patients were enrolled in the present study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2015</start_date>
  <completion_date type="Actual">May 30, 2019</completion_date>
  <primary_completion_date type="Actual">May 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D levels</measure>
    <time_frame>1 year</time_frame>
    <description>Evaluation of serum Vitamin D levels</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">168</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>1 - Controls</arm_group_label>
    <description>Control Healthy controls</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 - SSc</arm_group_label>
    <description>SSc Systemic Sclerosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 - Cardiovascular</arm_group_label>
    <description>Cardiovascular Cardiovascular disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 - SSc+Periodontitis</arm_group_label>
    <description>SSc+ Periodontitis Systemic Sclerosis with Periodontitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Evaluation of Vitamin D levels and correlation of Vitamin D levels level with periodontal and cardiovascular disease</description>
    <arm_group_label>1 - Controls</arm_group_label>
    <arm_group_label>2 - SSc</arm_group_label>
    <arm_group_label>3 - Cardiovascular</arm_group_label>
    <arm_group_label>4 - SSc+Periodontitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        42 patients with SSc, 43 patients with CHD, 41 patients with both SSc and CP, and 42
        healthy patients were enrolled in the present study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of at least twenty teeth

          -  CP with a minimum of 40% of sites with a clinical attachment level (CAL)

             ≥2mm and probing depth (PD) ≥4mm;

          -  Presence of at least ≥2 mm of crestal alveolar bone loss verified on digital
             periapical radiographs

          -  Presence of ≥40% sites with bleeding on probing (BOP)

        Exclusion Criteria:

          -  Intake of contraceptives

          -  Intake of immunosuppressive or anti-inflammatory drugs throughout the last three
             months prior to the study

          -  Status of pregnancy or lactation

          -  Previous history of excessive drinking

          -  Allergy to local anaesthetic

          -  Intake of drugs that may potentially determine gingival hyperplasia such as Hydantoin,
             Nifedipine, Cyclosporin A or similar drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaetano Isola</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Catania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Messina</name>
      <address>
        <city>Messina</city>
        <zip>98125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 22, 2019</study_first_submitted>
  <study_first_submitted_qc>August 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2019</study_first_posted>
  <last_update_submitted>August 22, 2019</last_update_submitted>
  <last_update_submitted_qc>August 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Messina</investigator_affiliation>
    <investigator_full_name>Gaetano Isola, DDS, PhD</investigator_full_name>
    <investigator_title>Junior Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all collected IPD, all IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Public register</ipd_time_frame>
    <ipd_access_criteria>Policlinic Messina website</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

